Final Report Summary - ENF2005 (EuroNanoForum2005 - Nanotechnology and the Health of the EU Citizen in 2020) EURONANOFORUM2005 explored several critical issues, such as the ongoing competitiveness of the European healthcare industries; meeting the demands of an ageing population, the early diagnosis and potential cures, for example, of cancer, cardiovascular disease, and inflammatory diseases. It demonstrated the potential of nanotechnologies to address these issues, support the creation of high quality jobs, and underpin important European Union (EU) objectives such as the Lisbon Agenda. The conference built on the success of EURONANOFORUM2002, and promoted developments in nanotechnology that are leading to innovative solutions for health and healthcare in Europe as part of an integrated and responsible approach. The format was a combination of workshops-on-demand, public debate, forums, and conference showing the state-of-the-art.% LWorkshops-on-Demand (WoD) were held all day on the Monday with topics proposed by relevant organisations and groups. Several of these groups were European Commission (EC) funded project based, others looking at specific topics and organised by relevant organisations, some by the United Kingdom MNT Network, and one by a group of commercial lawyers and patent agents brought together by the IoN to jointly present a collaborative workshop. Public debate describing the potential benefits of nanomedicine. This evening event was chaired by Susan Watts, science editor BBC Newsnight. There was a panel of four experts from across disciplines who briefly presented the potential in their field followed by questions from the floor. The questions followed two main themes: the way nanomedicine / technology is portrayed in the press and scientific questions on particular technologies. In addition to the public, delegates from the conference attended. Some ninety two speakers from over thirty countries made presentations in a combination of plenary and parallel sessions. The focus was science that would benefit the citizen of 2020. It was specifically not a scientist-to-scientist conference. It mixed industry with leading academics and, most importantly, was multi-disciplinary. Each session had a relevant chair and co-chair, the latter usually from a relevant unit of the European Union. 38 companies and organisations exhibited at the event. Around half of these were United Kingdom Small and medium-sized enterprises (SMEs) looking to showcase their technology. The exhibition was open from Tuesday until Friday. The post-event internal IoN review noted that one success was the combined exhibition, poster displays, and catering. This ensured a large footfall for exhibitors. 93 posters were exhibited. A number of these were from sponsored students whose attendance had been fully funded. The poster session was in the same area as the exhibition. All Scottish schools were invited to send a delegation of 15 - 16 year old pupils interested in a career in science, together with their teachers. The event was over an afternoon starting with an actor describing life in 2020, talks by invited speakers, and a special tour of the exhibition. Related documents Final Report - ENF2005 (EuroNanoForum2005 - Nanotechnology and the Health of the EU Citizen in 2020) Other documents EuroNanoForum 2005: Nanotechnology and the Health of the EU Citizen in 2020, European and International Forum on Nanotechnology, Edinburgh (UK) 5-9 September 2005, Conference Proceedings, EUR 21717
